Archean Chemical Industries Limited reported a strong performance for the first quarter of Fiscal Year 2027 (Q1 FY27), with total revenue growing by 11% YoY to Rs. 3,328 million. This growth was primarily driven by an improving product mix. The company also highlighted developments in its Bromine and Bromine Derivatives segments, with Bromine revenues increasing by 58% YoY. The presentation covers key performance highlights, company overview, and future strategic initiatives, including diversification into new frontiers like semiconductor manufacturing and energy storage.
Archean Chemical Industries: Q1 FY27 Performance Highlights
Archean Chemical Industries Limited has announced its financial results for the first quarter of Fiscal Year 2027 (Q1 FY27), showcasing a notable 11% year-on-year growth in total revenue, reaching Rs. 3,328 million. This increase was attributed to an improved product mix. The company’s performance was detailed in a presentation shared on August 1, 2026, for its earnings call.
Segment Performance Overview
- Total Revenue: Grew by 11% YoY to Rs. 3,328 million, driven by an improved product mix.
- Exports: Contributed significantly, approximately two-thirds of total revenue, but were impacted by the West Asia conflict, leading to higher transit times and freight costs.
- Industrial Salt: Segment revenue saw a 12% de-growth to Rs. 1,713 million with volumes of 0.98 million tons, affected by logistical and transportation challenges.
- Bromine: Revenues surged by 58% YoY to Rs. 1,333 million, supported by improved volumes (4,175 tons) and firmer realisations.
- Bromine Derivatives (Acume Chemicals): Business grew by 28% to Rs. 296 million, turning EBITDA-positive at Rs. 19 Mn compared to a loss of Rs. 27 Mn in Q1 FY26.
- SOP (Sulphate of Potash): Revenue reached Rs. 113 million, with expectations to maintain business momentum.
- Idealis Mudchemie (Oren Hydrocarbon): Focus remains on operationalizing plants and ongoing certifications.
Standalone and Consolidated Financials
The Standalone Profit & Loss Statement for Q1 FY27 shows a Profit after Tax of Rs. 405 million, with basic EPS at Rs. 3.28. The Consolidated Profit & Loss Statement reported a Profit after Tax of Rs. 304 million for Q1 FY27, with basic EPS at Rs. 2.48. The consolidated total income stood at Rs. 3,622 million for Q1 FY27.
Strategic Diversification and Future Outlook
Archean Chemical Industries is actively pursuing diversification strategies, including a focus on specialty chemicals and emerging sectors. The company is investing in:
- Semiconductors: Establishing India’s first SiC Semiconductor Fab and Packaging Unit through its subsidiary SiCSem Private Limited, with a strategic investment in Clas-SiC Wafer Fab Limited, UK.
- Energy Storage: Strategically acquiring Offgrid Energy Labs, which develops Zinc Bromide-based battery technology, aligning with the company’s bromine business synergy.
- New Product Development: Including Flame Retardant Bromine and further expansion in Bromine Derivatives.
The company’s history highlights its evolution from strategic investments to commenced operations, expansion phases, strategic expansion, and now unlocking new frontiers in advanced materials and energy solutions.
Source: BSE
